Bioventus Signs Lease for New Memphis Facility
Bioventus Signs Lease for New Memphis Facility
DURHAM, N.C. – Bioventus LLC, a leader in active orthopaedic healing, announced today the signing of a lease agreement for new office and manufacturing space off Goodlett Farms Parkway in Memphis, Tenn. at 1900 Charles Bryan Road. The company expects to move its Memphis-based employees into the 40,000-square-foot space in February 2013 following the build out of the new facility.
The company, formed in May as a strategic venture between Essex Woodlands and Smith & Nephew, occupies space at Smith & Nephew’s Brooks Road and Holmes Road locations. The move enables Bioventus to consolidate its Memphis functions, including operations, manufacturing, quality and human resources.
“Combining our functions in a single location not only provides facility cost benefits, but also increases our efficiency in terms of staff management and communications,” said Anthony James, VP of Operations and Quality for Bioventus. “The site is also strategically located near major transportation hubs, enabling us to provide rapid and cost-effective service for our customers.”
Bioventus currently has about 500 U.S. employees including about 130 in Memphis.
About Bioventus
Bioventus is a biologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. The company’s innovative products include market-leading devices, therapies and diagnostics that make it a global leader of active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine, and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
For more information, visit www.BioventusGlobal.com.
Bioventus Names David Price New Chief Financial Officer
Bioventus Names David Price New Chief Financial Officer
DURHAM, N.C. – Bioventus, a leader in active orthopaedic healing, today announced the appointment of David Price as its new chief financial officer. Price, who joins the company today, will be located in Bioventus’ corporate headquarters in Durham.
“David has a proven track record as a CFO in the finance and healthcare sectors, where he has significantly improved financial operations and positioned companies for long-term success,” said Mark Augusti, chief executive officer of Bioventus. “We’re confident in David, and know that his leadership on our executive team will help propel us forward.”
Price, 50, comes to Bioventus from EDGAR Online Inc. – a financial data, technology and business process outsourcing (BPO) company – where he served as CFO, chief operating officer and corporate treasurer. During his two years with the company, Price managed a team of more than 300 with responsibilities that included all financial strategy and reporting, investor relations, corporate development, human resources and BPO operations.
Prior to joining EDGAR Online, Price served as CFO and executive vice president of finance, corporate treasurer for Cornerstone Therapeutics, Inc., a Cary, N.C.-based, $120+ million publicly traded specialty pharmaceutical company. While at Cornerstone, he was named Ernst & Young CFO of the Year (2009) for small public companies.
Price had previously served as managing director in the healthcare sector at two investment banking firms – Jefferies & Company in New York, and Bear Stearns & Co. in London and New York – and worked at PricewaterhouseCoopers Consulting, Arthur Andersen and Lex Service PLC. He holds an honors degree in accounting and financial management from Lancaster University in the UK and is a member of the Institute of Chartered Accountants in England and Wales.
About Bioventus
Bioventus is a biologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. The company’s innovative products include market-leading devices, therapies and diagnostics that make it a global leader of active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine, and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
For more information, visit www.BioventusGlobal.com or follow the company on Facebook (www.facebook.com/bioventus) or Twitter (@BioventusGlobal or www.twitter.com/BioventusGlobal).
Bioventus and Esaote North America Bring Diagnostic Ultrasound and MRI to Musculoskeletal Market
Bioventus and Esaote North America Bring Diagnostic Ultrasound and MRI to Musculoskeletal Market
DURHAM, N.C. and INDIANAPOLIS, IN – Bioventus, a leader in active orthopaedic healing, and Esaote North America, a global leader in diagnostic ultrasound and magnetic resonance imaging, today announced an agreement for distributing Esaote’s products through Bioventus’ sales channel. Beginning immediately, Bioventus is the distributor of Esaote’s portable ultrasound solutions to U.S. orthopaedic clinics and practices focused on musculoskeletal conditions.
“We evaluated a number of ultrasound manufacturers and products to determine which would be the best fit for our company and our customers,” said Mark Augusti, chief executive officer of Bioventus. “We determined that Esaote’s product line complements our existing products and is the best ultrasound solution for orthopaedic customers, based on capabilities, ease-of-use and value.”
“Working with Bioventus enables us to reach a broader U.S. audience, based on the close relationships Bioventus currently has with orthopaedic physicians,” said Claudio Bertolini, president of Esaote North America. “We’re excited to work with a company that is trusted by physicians and known for its strong commitment to the customer.”
Bioventus is offering Esaote’s MyLab® One and MyLab Five ultrasound systems, which come complete with musculoskeletal presets and key functionality including enhanced needle visualization that enables accurate placement of therapeutic injections. Bioventus will also offer Esaote’s MRI, the O-Scan, a novel imaging solution for health care practitioners focused on injuries of the extremity. For more information on Esaote’s products, please visit www.esaoteusa.com.
About Bioventus
Bioventus is a biologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. The company’s innovative products include market-leading devices, therapies and diagnostics that make it a global leader of active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine, and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
For more information, visit www.BioventusGlobal.com or follow the company on Facebook (www.facebook.com/bioventus) or Twitter (@BioventusGlobal or www.twitter.com/BioventusGlobal).
About Esaote North America, Inc.
Esaote North America, headquartered in Indianapolis, Indiana, is a leading manufacturer and distributor of portable and console-based ultrasound and MRI equipment in the U.S. Established in 1979, Esaote North America is part of the international Esaote Group, a global leader in the research, production and marketing of medical diagnostic equipment. Esaote is among the largest manufacturers of ultrasound systems worldwide and prides itself on achieving superior price-performance over competitors through its focus on only ultrasound and office-based MRI medical equipment.
For more information, visit www.esaoteusa.com.
###
MyLab is a registered trademark of Esaote, S.p.A.
